Category Archives: FDA Policy

FDA Press Releases – What They Say

Keeping my eye on FDA, and being most interested in communications, AND having a penchant for looking at patterns through databases, I started categorizing FDA press releases to see what they talked about and in what way.  I only started … Continue reading

Posted in FDA Image, FDA Policy | Comments Off

Looking Back Down the Road – What Have We Learned from FDA on Regulation of Digital Media?

So last week there was a lot of interest and commentary on the issuance of a draft guidance by FDA that provided some insight into how the agency is regulating promotional speech and social media platforms.  It seemed like a … Continue reading

Posted in FDA Policy, Social Media | 1 Comment

Fewer Letters, Fewer Warning Letters

It may seem that I write a lot about the letters that FDA puts out regarding industry promotion and communication, but that is exactly what the nature of this blog is about. Other things can be interesting, particularly policy developments, … Continue reading

Posted in FDA Policy, Warning Letters | Comments Off

Now What? Post-Election and FDA

We are finally post-election.  The sense of relief that one can watch or listen to broadcast television or radio without seeing campaign ads is still being felt nationwide.  Facebook sidebars are free of political jabber and de-friending over politics has … Continue reading

Posted in FDA Policy, Legislation, Politics | Comments Off

FDLI Conference on Advertisting and Promotion

The Food and Drug Law Institute held its annual conference on Advertising and Promotion for the Pharmaceutical, Medical Device, Biologic and Veterinary Medicine Industries in Washington, D.C. on October 1 and 2.  I was able to attend sporadically and participated … Continue reading

Posted in FDA Policy, Medical Devices, New and Social Media | 1 Comment